Dr Wong Siew Wei Best Oncologist in Myanmar – Schedule Appointment
Dr. Wong Siew Wei is the best oncologist in Myanmar and Singapore, holding a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from the University of Melbourne, Australia. He was a Fellow of the Royal Australasian College of Physicians (FRACP) and has received specialized training in medical oncology in Victoria, Australia. Dr. Wong also possesses a medical diploma in palliative care from the Victorian Chapter of Palliative Medicine, Australia. Dr. Wong Siew Wei was a medical oncologist at Gleneagles Hospital, specializing in prostate, kidney, bladder, upper gastrointestinal, and lung cancers. Before his current practice, he held prominent positions at Johns Hopkins Singapore International Medical Centre (JHSIMC) and Tan Tock Seng Hospital (TTSH) as a consultant medical oncologist. He also contributed as a visiting consultant medical oncologist for the National Healthcare Group (NHG). Dr Wong actively participated in multidisciplinary tumour boards focusing on gastrointestinal, thoracic, and genitourinary malignancies during his tenure at JHSIMC and TTSH. His profound interest in advancing oncological treatments directed him to lead several clinical trials. Dr. Wong is recognized regionally as an invited speaker and has shared his expertise in various oncology meetings. His dedication to education extended to being the program director for NHG’s medical oncology training program. Additionally, he served as a valuable member of TTSH’s drug and therapeutics committee.
Overview: Dr Wong Siew Wei Best Oncologist in Myanmar, 2024
| Qualification | Experience | Specialty | Consultation Fees | Availability Time | ||
| MBBS (Melbourne) | 20 years | Medical Oncology | Please Contact us | Open 24 hours | ||
| FRACP | ||||||
Dr Wong Siew Wei Best Oncologist in Myanmar: Specialty
- Chemotherapy
- Immunotherapy
- Hormone therapy
- Targeted therapy
Dr Wong Siew Wei Awareness of Prostate Cancer Among Malaysian Men
Dr. Wong Siew Wei, a senior consultant and medical oncologist at Parkway Cancer Centre, brought attention to global prostate cancer statistics from 2020, showing over 1.4 million diagnosed cases worldwide. Addressing specific regional trends, Dr. Wong highlighted a significant rise in prostate cancer diagnoses in Malaysia, reporting 1,600 cases between 2012 and 2016. Notably, prostate cancer is now the third most dominant cancer among Malaysian men and the second among Singaporean men. Dr. Wong highlighted that ageing is a primary risk factor for prostate cancer, noting that increased male lifespan correlates with higher exposure to this disease. Additionally, he stressed the prevalence of prostate enlargement, urging men, primarily upon reaching 65 years of age, to remain attentive and proactive in monitoring their health for potential symptoms.
